Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481871
Status:
COMPLETED
Last Update Posted:
2020-01-07
First Post:
2007-06-01
Brief Title:
Study of Pralatrexate Gemcitabine With B12 Folic Acid to Treat RelapsedRefractory Lymphoproliferative Malignancies
Sponsor:
Acrotech Biopharma Inc
Organization:
Acrotech Biopharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Waldenstroms Macroglobulinemia |
| Relapsed or Refractory Lymphoproliferative Malignancies |
| Hodgkins Lymphoma |
| Peripheral T-cell Lymphoma |
| B-cell Lymphoma |
Keywords:
| Name | View |
|---|---|
| Folic acid | View |
| Lymphoproliferative malignancies | View |
| Lymphoma | View |
| Hodgkins lymphoma HL | View |
| Non-Hodgkins lymphoma NHL | View |
| PTCL | View |
| TNK-cell leukemialymphoma | View |
| T-cell lymphomaleukemia HTLV 1 | View |
| Angioimmunoblastic T-cell lymphoma | View |
| Blastic NK lymphoma | View |
| Anaplastic large cell lymphoma | View |
| TNK-cell lymphoma | View |
| Enteropathy-type intestinal lymphoma | View |
| Hepatosplenic T-cell lymphoma | View |
| Extranodal peripheral TNK-cell lymphoma | View |
| Subcutaneous panniculitis T-cell lymphoma | View |
| Transformed mycosis fungoides | View |
| PDX | View |
| Pralatrexate | View |
| Gemcitabine | View |
| Gemzar | View |
| Vitamin B12 | View |